SMi Group announces the 9th Annual RNA Therapeutics Conference in London on February 21st – 22nd 2018.
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.http://bit.ly/2xtvCH1
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and evaluate with key industry leaders the lessons they’ve learnt whilst developing an RNA therapeutic. The full speaker line-up and conference agenda is available at http://www.therapeutics-rna.com/bnths
Journal: Current Pharmaceutical Design
EBook: Frontiers in RNAi